Free Trial

Quantum Biopharma (QNTM) SEC Filings & 10K Form

Quantum Biopharma logo
$17.25 +0.50 (+2.99%)
Closing price 08/28/2025 04:00 PM Eastern
Extended Trading
$17.48 +0.23 (+1.31%)
As of 08/28/2025 07:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Quantum Biopharma SEC Filings

DateFilerForm TypeView
08/21/2025
6:00 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/11/2025
6:40 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/08/2025
7:00 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2025
6:00 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/05/2025
6:34 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/04/2025
6:33 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/31/2025
6:24 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/22/2025
6:00 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/18/2025
1:44 PM
Malone Wealth Ventures LLC (Filed by)
Quantum Biopharma Ltd. (Subject)
Quantum Biopharma (Subject)
Form SCHEDULE 13G/A
07/10/2025
6:39 PM
Malone Wealth Ventures LLC (Filed by)
Quantum Biopharma Ltd. (Subject)
Quantum Biopharma (Subject)
Form SCHEDULE 13G/A
07/10/2025
6:44 PM
Malone Wealth Ventures LLC (Filed by)
Quantum Biopharma Ltd. (Subject)
Quantum Biopharma (Subject)
Form SCHEDULE 13G/A
07/10/2025
6:50 PM
Malone Wealth Ventures LLC (Filed by)
Quantum Biopharma Ltd. (Subject)
Quantum Biopharma (Subject)
Form SCHEDULE 13G/A
07/08/2025
7:00 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/30/2025
9:26 AM
Malone Wealth Ventures LLC (Filed by)
Quantum Biopharma Ltd. (Subject)
Quantum Biopharma (Subject)
Form SCHEDULE 13G/A
06/27/2025
3:30 PM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/26/2025
6:30 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/23/2025
2:34 PM
Malone Wealth Ventures LLC (Filed by)
Quantum Biopharma Ltd. (Subject)
Quantum Biopharma (Subject)
Form SCHEDULE 13D/A
06/23/2025
10:29 AM
Malone Wealth Ventures LLC (Filed by)
Quantum Biopharma Ltd. (Subject)
Quantum Biopharma (Subject)
Form SCHEDULE 13D/A
06/17/2025
7:00 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/16/2025
8:53 PM
Malone Wealth Ventures LLC (Filed by)
Quantum Biopharma Ltd. (Subject)
Quantum Biopharma (Subject)
Form SCHEDULE 13D/A
06/13/2025
6:00 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/12/2025
5:15 PM
Malone Wealth Ventures LLC (Filed by)
Quantum Biopharma Ltd. (Subject)
Quantum Biopharma (Subject)
Form SCHEDULE 13D
06/11/2025
2:26 PM
Malone Wealth Ventures LLC (Filed by)
Quantum Biopharma Ltd. (Subject)
Quantum Biopharma (Subject)
Form SCHEDULE 13G
06/10/2025
7:00 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/03/2025
6:50 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/30/2025
6:00 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2025
6:30 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2025
7:00 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2025
7:00 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/20/2025
6:30 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/19/2025
6:30 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/16/2025
6:30 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/12/2025
7:00 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/05/2025
9:01 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2025
6:00 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/22/2025
6:00 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/18/2025
8:34 PM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/14/2025
6:30 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/10/2025
6:30 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/03/2025
6:00 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/01/2025
5:00 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
This is my Christian duty (Ad)

“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.tc pixel

Watch Jim Rickards reveal the Old Testament Wealth Code
03/31/2025
6:00 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/28/2025
12:53 PM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/28/2025
5:09 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2025
6:00 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/26/2025
6:00 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/20/2025
6:30 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/26/2025
6:30 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2025
6:30 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/11/2025
6:30 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/10/2025
9:18 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/06/2025
6:30 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/04/2025
6:30 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/21/2025
3:00 PM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/17/2025
6:31 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/14/2025
7:30 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/07/2025
7:32 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/20/2024
8:16 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/25/2024
6:22 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/29/2024
6:31 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/22/2024
6:54 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/21/2024
7:50 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/07/2024
6:32 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2024
7:09 PM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
6:27 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/09/2024
6:39 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/06/2024
8:22 PM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/30/2024
8:46 AM
Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:QNTM) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners